Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Dehydration in health and social care
Phillipa Atkinson-Clow, General Manager of The Water Dispenser and Hydration Association, explains how in hospital and care settings, the issue of dehydration is all too common.
Canada: Infection & immunity focus
The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.
Hospitals of the future: The importance of digital transformation skills
Here, Fraunhofer Germany discuss how COVID-19 has driven the adoption of digital health technologies, and offers solutions aiding healthcare professionals to keep up.
Bioinformatics focus: Can we break the glycocode?
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, provides the computer-based tools for exploring ways of breaking the glycocode.
Real-time symptom tracking for long COVID
Katrina Delargy, Managing Director of TIYGA Health, tells us what we need to know about real-time symptom tracking for long COVID.
Social media data for social and behavioural research
Guangqing Chi and Junjun Yin from The Pennsylvania State University discuss how social media data has become a gold mine of information for both academic and non-academic use.
Energy saving products towards ‘net zero’
Adrian Polak, Product Manager at Endo Enterprises, showcases their multi-award-winning innovative energy saving products EndoTherm and EndoCool - Jump-start your race to ‘net zero’ with HVAC’s best kept secret weapon.
CureVac vaccine performs at 47% efficacy in latest trial
The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.
How are disparities in smoking highlighting the global issue of health inequality?
C3 Collaborating for Health is working to make it easier for everyone to make healthier choices, and here, we learn why this is particularly important for smokers.
Safeguarding Galapagos for the future
Why conserve Galapagos? Clare Simm from the Galapagos Conservation Trust answers this vital question, discussing the immense vulnerability of the islands and the work being done to protect them.
REACT study: Scientists say 90% of UK virus cases are Delta variant
The latest REACT figures show that 90% of UK virus cases are now the Delta variant, with the highest rates of infection in those aged 18-24
The Real-time Assessment of Community Transmission (REACT) programme was commissioned by the Department of Health, to officially track how COVID-19 is spreading.
How is Delta changing...
Scientists find “harmful chemicals” in over 75% of makeup
Scientists tested makeup across the US and Canada for harmful chemicals - they found that over 75% of products tested contained PFAS, which are "forever chemicals".
Assessing children’s post-lockdown reading development
Pamela Hanigan and Rachel Gelder, founders of Lancashire Dyslexia Information Guidance and Support (LDIGS), explain how teachers and SENDCos can assess children's post-lockdown reading development to give the best support to their learning back in the classroom.
New ‘superfungus’ emerges in Brazil during pandemic
Exhausted medical staff in Brazil have enough to deal with when it comes to COVID-19 - now, a new 'superfungus' has evolved beyond drug treatment.
The future of digital accessibility for the public sector
Ryan Graham, CTO, Texthelp Group, explores the future of online accessibility within the public sector, with reference to WCAG 3.0.
Towards a long-term Mental Health Strategy
Chairs of the Parliament’s Coalition for Mental Health and Wellbeing demand immediate action to address the growing mental health crisis and the creation of a long-term Mental Health Strategy.
Advancing digital transformation and modern data protection
2020 was a year of IT change. Jeremy Wyatt, Operations Director at FCS explains how the last year has affected IT, Digital Transformation and modern data protection strategy.
PHE study finds AstraZeneca vaccine 92% effective against Delta variant
Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.
PCR Biosystems: Scaling up the production of critical reagents in a crisis
Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.
European Commission launches EU Digital COVID Certificate
Today (14 June) the Commission formally signed legislation to create the EU Digital COVID Certificate - which will be used for 12 months, beginning from 1 July, 2021.